Hypothermic Perfusion Preservation Market Size is predicted to represent a 10.26% CAGR during the forecast period for 2023-2031.
The Hypothermic Perfusion Preservation Market refers to the industry that revolves around the use of hypothermic perfusion preservation techniques for the storage and transportation of organs intended for transplantation. This market is dynamic, driven by continuous research, technological advancements, and the rising global demand for efficient organ preservation techniques. Furthermore, the ongoing increase in healthcare expenditures in both developed and developing nations is a key factor contributing to the expansion of the hypothermic perfusion preservation market. Substantial investments in healthcare infrastructure, including specialized facilities for organ transplants, have facilitated the adoption of advanced preservation techniques, making a significant contribution to market growth.
However, the initial investment and continuous operational costs associated with hypothermic perfusion preservation devices are considerably high. Financial challenges stem from the expenses related to procuring and maintaining the equipment, as well as acquiring specialized preservation solutions. This economic burden poses a significant obstacle to the widespread adoption of these technologies, particularly in healthcare settings with limited resources
Competitive Landscape
Some Major Key Players In The Hypothermic Perfusion Preservation Market:
- Organ Recovery Systems
- XVIVO Perfusio
- Paragonix Technologie
- TransMedics
- Bridge to Life Ltd
- Preservation Solutions Inc.
- OrganOx
- Organ Assist
- Waters Medical Systems LLC
- Preservation Sciences Inc.,
- 21st Century Medicine (US),
- Shanghai Genext Medical Technology (China)
- Carnamedica (Poland),
- Transplant Biomedicals (Spain),
- Institut Georges Lopez (France),
- Global Transplant Solutions (US),
- Bridge to Life Limited (US)
- Avionord
- Others
Market Segmentation:
The hypothermic perfusion preservation market is segmented on the basis of end users and organ type. Based on end users, the hypothermic perfusion preservation market is segmented into hospitals, organ procurement organizations (OPOs), and transplant centres. By organ type, the market is segmented into heart, lungs, liver, kidneys, and others.
Based On End-Users, The Transplant Centres Segment Is A Major Contributor In The Hypothermic Perfusion Preservation Market.
The transplant centres category is expected to hold a major share of the global Hypothermic Perfusion Preservation market in 2022. Specialized centres necessitate sophisticated preservation techniques to guarantee the viability of organs during their transportation and transplantation. Additionally, the increasing incidences of chronic diseases and organ failures have heightened the demand for effective organ preservation, leading to the widespread adoption of hypothermic perfusion preservation systems in transplant centres. This surge in adoption is contributing to the rapid growth of this segment.
The Kidney Segment Witnessed Growth At A Rapid Rate.
The kidney segment is projected to grow at a rapid rate in the global hypothermic perfusion preservation market. Because of the widespread occurrence of end-stage renal disease and the consequent global demand for kidney transplants, there is an increased necessity for effective preservation techniques. The rising prevalence of conditions like diabetes and hypertension, which can result in kidney failure, has further heightened the demand. Moreover, the notable progress in hypothermic perfusion preservation technology has notably enhanced the success rates of kidney transplantation, solidifying the dominance of the kidney segment in the market.
In The Region, The North American Hypothermic Perfusion Preservation Market Holds A Significant Revenue Share.
The North America Hypothermic Perfusion Preservation market is expected to register the highest market share. In North America, increased investments in healthcare, including specialized facilities for organ transplants, have fostered the adoption of advanced preservation techniques. This positive trend has led to substantial growth in the market, reflecting a commitment to ensuring the effectiveness of organ transplantation procedures. In addition, Asia Pacific is estimated to grow at a rapid rate in the global hypothermic perfusion preservation market. Ongoing research, continuous technological advancements, and a growing demand for efficient organ preservation techniques characterize the market in APAC.
Recent Developments
- In Aug 2023, Specific assets of Bridge to Life Ltd. (BTL) were sold to TransMedics, Inc. BTL intends to concentrate on its primary preservation solutions business and its forthcoming Food and Drug Administration (FDA) application for the VitaSmart™ Liver Machine Perfusion System with the funds obtained from the sale of these assets.
- In July 2021, TransMedics Group, Inc. received authorization from the U.S. FDA for their OCS™ Lung Solution to be used in transplants involving cold storage procedures. The solution, a constituent of the company's OCS Lung System, is used for hypothermic flushing, storage, and transportation of donor lungs for transplantation.
Hypothermic Perfusion Preservation Market Report Scope
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 10.26% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By End-Users, Organ Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Organ Recovery Systems, XVIVO Perfusion, Paragonix Technologies, TransMedics, Bridge to Life Ltd., Preservation Solutions Inc., OrganOx, Organ Assist, Waters Medical Systems LLC, and Preservation Sciences Inc., 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Bridge to Life Limited (US), Avionord, Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
